< Back to latest news & events

Knowledge Hub

Coronavirus update: Oral proceedings before Opposition Divisions and Boards of Appeal

August 2020

In view of the ongoing disruptions caused by the spread of Coronavirus (COVID-19), the European Patent Office (EPO) has implemented special measures for arrangement and conduct of oral proceedings. These measures are now updated with respect to oral proceedings before Opposition Divisions and Boards of Appeal. Oral proceedings in examination will continue to be held by videoconference.

Oral proceedings before Opposition Divisions

The EPO has decided to postpone oral proceedings in opposition scheduled until 31 December 2020 (previously until 14 September 2020).

Cases affected are those that have not already been confirmed to take place by videoconference or will be held by videoconference with the parties’ consent under the Pilot Project for oral proceedings. Under the Pilot Project (Article 2 of the Decision of the President of the EPO dated 14 April 2020) oral proceedings before Opposition Divisions may be held by videoconference at the discretion of the Opposition Division and with the agreement of all parties. The parties will be informed about the postponement of oral proceedings in affected cases as soon as possible.

The EPO intends to maintain oral proceedings in opposition which have been scheduled to take place on the premises of the EPO on or after 4 January 2021.

Oral proceedings before Boards of Appeal

The EPO has also decided to discontinue the recently introduced practice of contacting parties to enquire whether they are able to attend oral proceedings before the Boards of Appeal. If parties cannot attend oral proceedings for which they have been summoned, they will now have to request a change of date (Article 15(2) RPBA 2020).

In addition, owing to the need for physical distancing, venues and/or starting times for oral proceedings may be changed without informing parties. As such, changes may take place at short notice, and it is up to the parties to consult the online calendar approximately three days before their oral proceedings to check whether they will take place on the Haar premises or in the Isar building and when exactly they are scheduled to start.

See the official notice here.

This update was prepared by HGF Senior European Patent Attorney Dr Alex Colman. If you would like further advice on this or any other matter, please contact Alex.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details